Abstract
Purpose
Most of the literature on liver abscess in chronic granulomatous disease (CGD) emanates from developed countries. Data from developing countries are scarce. In this study, we report clinical features, microbiological profile, and treatment difficulties encountered while managing liver abscesses in patients with CGD at a tertiary care centre in North-West India.
Methodology
Case records of children with CGD and liver abscesses at Pediatric Immunodeficiency Clinic, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India were analyzed.
Results
Seven of 68 patients (10.29%) with CGD presented with hepatic abscess. One patient had 2 recurrences. All were males and age-range at presentation was 7 months–22 years. Mutation analysis was carried out in all patients—3 had defects in CYBB gene; 2 in NCF1; 2 in NCF2 gene. Staphylococcus aureus was isolated from 5 patients. Duration of antimicrobial treatment ranged from 3 weeks to 7 months. Open drainage was required in 1 patient, and 1 patient was treated with a prolonged course of prednisolone. Two children succumbed to the illness.
Conclusions
This is the largest reported experience of liver abscesses in patients with CGD from the developing world. Staphylococcus aureus was the commonest pathogen isolated. In our experience, prolonged courses of antimicrobials are usually necessary in these patients. Glucocorticoids can reduce inflammatory response and facilitate early resolution of abscesses in CGD.
Similar content being viewed by others
Abbreviations
- AR:
-
Autosomal recessive
- BAL:
-
Bronchoalveolar lavage
- CECT:
-
Contrast-enhanced computerized tomography
- CGD:
-
Chronic granulomatous disease
- CRP:
-
C-reactive protein
- DHR:
-
Dihydrorhodamine
- ESR:
-
Erythrocyte sedimentation rate
- IUIS:
-
International Union of Immunological Societies
- IV:
-
Intravenous
- MRI:
-
Magnetic resonance imaging
- MRSA:
-
Methicillin-resistant Staphylococcus aureus
- MSSA:
-
Methicillin-sensitive Staphylococcus aureus
- NBT:
-
Nitro blue tetrazolium test
- SI:
-
Stimulation index
- XL:
-
X-linked
References
Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS Phenotypical classification. J Clin Immunol. 2020;40(1):66–81.
Holland SM. Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013;27(1):89–99.
Roos D. Chronic granulomatous disease. Br Med Bull. 2016 Jun;118(1):50–63.
Seger RA. Modern management of chronic granulomatous disease. Br J Haematol. 2008;140(3):255–66.
Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79(3):170–200.
van den Berg JM, van Koppen E, Åhlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European Experience. PLoS ONE. 2009;4(4):e5234. https://doi.org/10.1371/journal.pone.0005234.
Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79(3):155–69.
Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, et al. Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India. J Clin Immunol. 2014;34(1):58–67.
Rawat A, Bhattad S, Singh S. Chronic granulomatous disease. Indian J Pediatr. 2016;83(4):345–53.
Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, Mansouri SD, et al. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol. 2011;31(5):792–801.
Köker MY, Camcıoğlu Y, van Leeuwen K, Kılıç SŞ, Barlan I, Yılmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol. 2013;132(5):1156–1163.e5.
Jindal AK, Pilania RK, Rawat A, Singh S. Primary immunodeficiency disorders in India-a situational review. Front Immunol. 2017;8:714.
Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, Krishnaswamy G. Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin Mol Allergy CMA. 2011;9(1):10.
Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatol Baltim Md. 2007;45(3):675–83.
Marciano BE, Spalding C, Fitzgerald A, Mann D, Brown T, Osgood S, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;60(8):1176–83.
Lublin M, Bartlett DL, Danforth DN, Kauffman H, Gallin JI, Malech HL, et al. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg. 2002;235(3):383–91.
Pilania RK, Arora A, Agarwal A, Jindal AK, Aggarwal K, Krishnan G, et al. Linezolid-induced mitochondrial toxicity presenting as retinal nerve fiber layer microcysts and optic and peripheral neuropathy in a patient with chronic granulomatous disease. Retin Cases Brief Rep. 2018. https://doi.org/10.1097/ICB.0000000000000777.
Pilania RK, Prithvi A, Nambiyar K, Gupta K, Rawat A. Revisiting fatal granulomatous disease of childhood through an autopsy: still lethal in the developing world. J Clin Immunol. 2019;39(3):241–4.
Kulkarni M, Hule G, de Boer M, van Leeuwen K, Kambli P, Aluri J, et al. Approach to molecular diagnosis of chronic granulomatous disease (CGD): an experience from a large cohort of 90 Indian patients. J Clin Immunol. 2018;38(8):898–916.
Rawat A, Vignesh P, Sharma A, Shandilya JK, Sharma M, Suri D, et al. Infection profile in chronic granulomatous disease: a 23-year experience from a tertiary Care Center in North India. J Clin Immunol. 2017;37(3):319–28.
Gao L, Yin Q, Tong Y, Gui J, Liu X, Feng X, et al. Clinical and genetic characteristics of Chinese pediatric patients with chronic granulomatous disease. Pediatr Allergy Immunol. 2019;30(3):378–86.
Conti F, Lugo-Reyes SO, Blancas Galicia L, He J, Aksu G, Borges de Oliveira E, et al. Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases. J Allergy Clin Immunol. 2016;138(1):241–248.e3.
Pilania RK, Chaudhary H, Jindal AK, Rawat A, Singh S. Current status and prospects of primary immunodeficiency diseases in Asia. Genes Dis. 2020;7(1):3–11.
Garcia-Eulate R, Hussain N, Heller T, Kleiner D, Malech H, Holland S, et al. CT and MRI of hepatic abscess in patients with chronic granulomatous disease. Am J Roentgenol. 2006;187(2):482–90.
Chen LE, Minkes RK, Shackelford PG, Strasberg SM, Kuo EY, Langer JC. Cut it out: managing hepatic abscesses in patients with chronic granulomatous disease. J Pediatr Surg. 2003;38(5):709–13.
Bakri FG, Martel C, Khuri-Bulos N, Mahafzah A, El-Khateeb MS, Al-Wahadneh AM, et al. First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families. J Clin Immunol. 2009;29(2):215–30.
Kiat MO, Boisson-Dupuis S, Casanova JL, Bustamante J, Gepte MBP, Santos JA. Chronic granulomatous disease: unreported mutation. PIDSP. 2017;18(1):45–53.
Shin K-S, Lee MS. Concomitant use of corticosteroid and antimicrobials for liver abscesses in patients with chronic granulomatous disease. Korean J Pediatr. 2016;59(4):196–201.
Leiding JW, Freeman AF, Marciano BE, Anderson VL, Uzel G, Malech HL, et al. Corticosteroid therapy for liver abscess in chronic granulomatous disease. Clin Infect Dis. 2012;54(5):694–700.
Straughan DM, McLoughlin KC, Mullinax JE, Marciano BE, Freeman AF, Anderson VL, et al. The changing paradigm of management of liver abscesses in chronic granulomatous disease. Clin Infect Dis. 2018;66(9):1427–34.
Yamazaki-Nakashimada MA, Stiehm ER, Pietropaolo-Cienfuegos D, Hernandez-Bautista V, Espinosa-Rosales F. Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2006;97(2):257–61.
Conte D, Fraquelli M, Capsoni F, Giacca M, Zentilin L, Bardella MT. Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease. J Interf Cytokine Res. 1999;19(7):705–10.
The International Chronic Granulomatous Disease Cooperative Study Group*. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med. 1991;324(8):509–16.
Slack MA, Thomsen IP. Prevention of infectious complications in patients with chronic granulomatous disease. J Pediatr Infect Dis Soc. 2018;7(suppl_1):S25–30.
Acknowledgments
We sincerely thank the patients and their parents for their cooperation.
Disclaimer
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Funding
This study is funded by the Indian Council of Medical Research, New Delhi and Department of Health Research, Ministry of Health and Family Welfare, Government of India, New Delhi Grant No GIA/48/2014-DHR to SS, and The Foundation for Primary Immunodeficiencies (FPID), USA.
YLL was supported by The Society for Relief of Disabled Children for genetic sequencing.
Author information
Authors and Affiliations
Contributions
RKP and AR designed the research.
RKP, AR, PV, GD, SS, AKJ, GD, DS, AG, KG, KWC, YLL, KI, and SS performed the research.
RKP, AR, PV, and SS wrote the paper.
AR, KWY, YLL, and KI performed the genetic analysis of these patients.
KG performed histopathological examination. AR and SS critically supervised the manuscript.
All the authors read and approve the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest
Ethical Approval
This study was approved by Departmental Review Board at the Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Supplementary Figure 1
Course of illness in case 1 (Abbreviations: CGD: Chronic granulomatous disease; IV: Intravenous; MSSA: Methicillin sensitive Staphylococcus aureus; MRSA; Methicillin resistant Staphylococcus aureus; USG: Ultrasonogram) (JPG 145 kb)
Rights and permissions
About this article
Cite this article
Pilania, R.K., Rawat, A., Vignesh, P. et al. Liver Abscess in Chronic Granulomatous Disease—Two Decades of Experience from a Tertiary Care Centre in North-West India. J Clin Immunol 41, 552–564 (2021). https://doi.org/10.1007/s10875-020-00938-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-020-00938-9